Certara’s Secondary Intelligence Software Predicts Likelihood of New Drug Candidates Causing Safety Concerns
Category: Software/Services
Developers: Certara
United States
Product Description:Certara’s Secondary Intelligence software assembles, curates, and visualizes secondary pharmacology analyses. It assesses, and quantitatively rates, the likelihood of new drug candidates producing off-target activity, causing safety concerns. Early identification of this potential activity helps to reduce the incidence of adverse drug reactions, which could impede candidates’ clinical progress.
Developers: Certara
United States
Product Description:Certara’s Secondary Intelligence software assembles, curates, and visualizes secondary pharmacology analyses. It assesses, and quantitatively rates, the likelihood of new drug candidates producing off-target activity, causing safety concerns. Early identification of this potential activity helps to reduce the incidence of adverse drug reactions, which could impede candidates’ clinical progress.
Secondary Intelligence Screenshot